Type |
Details |
Score |
Publication |
First Author: |
Yamaguchi J |
Year: |
2024 |
Journal: |
Cancer Med |
Title: |
Trefoil factor 1 suppresses stemness and enhances chemosensitivity of pancreatic cancer. |
Volume: |
13 |
Issue: |
11 |
Pages: |
e7395 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dosch JS |
Year: |
2015 |
Journal: |
Cancer Res |
Title: |
Cancer stem cell marker phenotypes are reversible and functionally homogeneous in a preclinical model of pancreatic cancer. |
Volume: |
75 |
Issue: |
21 |
Pages: |
4582-92 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen Y |
Year: |
2022 |
Journal: |
Cancer Cell |
Title: |
Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer. |
Volume: |
40 |
Issue: |
8 |
Pages: |
818-834.e9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nishikawa Y |
Year: |
2019 |
Journal: |
Oncogene |
Title: |
Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis. |
Volume: |
38 |
Issue: |
22 |
Pages: |
4283-4296 |
|
•
•
•
•
•
|
Publication |
First Author: |
Astuti Y |
Year: |
2024 |
Journal: |
Nat Cancer |
Title: |
Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. |
Volume: |
5 |
Issue: |
5 |
Pages: |
774-790 |
|
•
•
•
•
•
|
Publication |
First Author: |
Krebs AM |
Year: |
2017 |
Journal: |
Nat Cell Biol |
Title: |
The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. |
Volume: |
19 |
Issue: |
5 |
Pages: |
518-529 |
|
•
•
•
•
•
|
Publication |
First Author: |
Philip B |
Year: |
2013 |
Journal: |
Gastroenterology |
Title: |
A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. |
Volume: |
145 |
Issue: |
6 |
Pages: |
1449-58 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim KS |
Year: |
2019 |
Journal: |
JCI Insight |
Title: |
Glycemic effect of pancreatic preproglucagon in mouse sleeve gastrectomy. |
Volume: |
4 |
Issue: |
20 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Cigliola V |
Year: |
2018 |
Journal: |
Nat Cell Biol |
Title: |
Pancreatic islet-autonomous insulin and smoothened-mediated signalling modulate identity changes of glucagon+ α-cells. |
Volume: |
20 |
Issue: |
11 |
Pages: |
1267-1277 |
|
•
•
•
•
•
|
Publication |
First Author: |
Houtz J |
Year: |
2016 |
Journal: |
Dev Cell |
Title: |
Neurotrophin Signaling Is Required for Glucose-Induced Insulin Secretion. |
Volume: |
39 |
Issue: |
3 |
Pages: |
329-345 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wasylishen AR |
Year: |
2020 |
Journal: |
Sci Adv |
Title: |
Daxx maintains endogenous retroviral silencing and restricts cellular plasticity in vivo. |
Volume: |
6 |
Issue: |
32 |
Pages: |
eaba8415 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim ER |
Year: |
2015 |
Journal: |
J Neurosci |
Title: |
Hypothalamic Non-AgRP, Non-POMC GABAergic Neurons Are Required for Postweaning Feeding and NPY Hyperphagia. |
Volume: |
35 |
Issue: |
29 |
Pages: |
10440-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lorberbaum DS |
Year: |
2020 |
Journal: |
Development |
Title: |
Retinoic acid signaling within pancreatic endocrine progenitors regulates mouse and human β cell specification. |
Volume: |
147 |
Issue: |
12 |
|
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Hmga2/Hmga2<+> Kras/Kras<+> Tg(Pdx1-cre)6Tuv/? Trp53/Trp53<+> |
Background: |
involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd9/Cd9<+> Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Kras/Kras<+> Tg(Pdx1-cre)6Tuv/? Trp53/Trp53 |
Background: |
involves: 129P2/OlaHsd * 129S4/SvJae * 129X1/SvJ * C57BL/6N * FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd9/Cd9 Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Kras/Kras<+> Tg(Pdx1-cre)6Tuv/? Trp53/Trp53<+> |
Background: |
involves: 129P2/OlaHsd * 129S4/SvJae * 129X1/SvJ * C57BL/6N * FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd9/Cd9 Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Kras/Kras<+> Tg(Pdx1-cre)6Tuv/? Trp53/Trp53 |
Background: |
involves: 129P2/OlaHsd * 129S4/SvJae * 129X1/SvJ * C57BL/6N * FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd9/Cd9<+> Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Kras/Kras<+> Tg(Pdx1-cre)6Tuv/? Trp53/Trp53<+> |
Background: |
involves: 129P2/OlaHsd * 129S4/SvJae * 129X1/SvJ * C57BL/6N * FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Kras/Kras<+> Tg(Pdx1-cre)89.1Dam/? Trim29/Trim29 Trp53/Trp53<+> |
Background: |
involves: 129 * C57BL/6 * CBA |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Kras/Kras<+> Tg(Pdx1-cre)89.1Dam/? Trim29/Trim29 |
Background: |
involves: 129 * C57BL/6 * CBA |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor Tg(Pdx1-flpo)#Ybi/? |
Background: |
involves: 129S4/SvJaeSor * 129S6/SvEvTac |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Baumel-Alterzon S |
Year: |
2024 |
Journal: |
Diabetologia |
Title: |
NRF2 is required for neonatal mouse beta cell growth by maintaining redox balance and promoting mitochondrial biogenesis and function. |
Volume: |
67 |
Issue: |
3 |
Pages: |
547-560 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
780
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
220
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
218
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
935
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
802
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Marcheva B |
Year: |
2010 |
Journal: |
Nature |
Title: |
Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. |
Volume: |
466 |
Issue: |
7306 |
Pages: |
627-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Collier JJ |
Year: |
2020 |
Journal: |
Mol Metab |
Title: |
Pancreatic, but not myeloid-cell, expression of interleukin-1alpha is required for maintenance of insulin secretion and whole body glucose homeostasis. |
Volume: |
44 |
|
Pages: |
101140 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yu V |
Year: |
2024 |
Journal: |
Diabetologia |
Title: |
Differential CpG methylation at Nnat in the early establishment of beta cell heterogeneity. |
Volume: |
67 |
Issue: |
6 |
Pages: |
1079-1094 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pasek RC |
Year: |
2013 |
Journal: |
Am J Physiol Endocrinol Metab |
Title: |
Advancements and challenges in generating accurate animal models of gestational diabetes mellitus. |
Volume: |
305 |
Issue: |
11 |
Pages: |
E1327-38 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ferreira RMM |
Year: |
2017 |
Journal: |
Cell Rep |
Title: |
Duct- and Acinar-Derived Pancreatic Ductal Adenocarcinomas Show Distinct Tumor Progression and Marker Expression. |
Volume: |
21 |
Issue: |
4 |
Pages: |
966-978 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tsuyama T |
Year: |
2023 |
Journal: |
EMBO Rep |
Title: |
Hypoxia causes pancreatic β-cell dysfunction and impairs insulin secretion by activating the transcriptional repressor BHLHE40. |
Volume: |
24 |
Issue: |
8 |
Pages: |
e56227 |
|
•
•
•
•
•
|
Publication |
First Author: |
Maddocks ODK |
Year: |
2017 |
Journal: |
Nature |
Title: |
Modulating the therapeutic response of tumours to dietary serine and glycine starvation. |
Volume: |
544 |
Issue: |
7650 |
Pages: |
372-376 |
|
•
•
•
•
•
|
Publication |
First Author: |
Marquard J |
Year: |
2015 |
Journal: |
Nat Med |
Title: |
Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment. |
Volume: |
21 |
Issue: |
4 |
Pages: |
363-72 |
|
•
•
•
•
•
|
Publication |
First Author: |
Daley D |
Year: |
2016 |
Journal: |
Cell |
Title: |
γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation. |
Volume: |
166 |
Issue: |
6 |
Pages: |
1485-1499.e15 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hruban RH |
Year: |
2006 |
Journal: |
Cancer Res |
Title: |
Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. |
Volume: |
66 |
Issue: |
1 |
Pages: |
95-106 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang G |
Year: |
2017 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
p53 pathway is involved in cell competition during mouse embryogenesis. |
Volume: |
114 |
Issue: |
3 |
Pages: |
498-503 |
|
•
•
•
•
•
|
Publication |
First Author: |
Todoric J |
Year: |
2017 |
Journal: |
Cancer Cell |
Title: |
Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas. |
Volume: |
32 |
Issue: |
6 |
Pages: |
824-839.e8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Maruno T |
Year: |
2021 |
Journal: |
Elife |
Title: |
Visualization of stem cell activity in pancreatic cancer expansion by direct lineage tracing with live imaging. |
Volume: |
10 |
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Lee JW |
Year: |
2019 |
Journal: |
Nature |
Title: |
Hepatocytes direct the formation of a pro-metastatic niche in the liver. |
Volume: |
567 |
Issue: |
7747 |
Pages: |
249-252 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ruess DA |
Year: |
2018 |
Journal: |
Nat Med |
Title: |
Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase. |
Volume: |
24 |
Issue: |
7 |
Pages: |
954-960 |
|
•
•
•
•
•
|
Publication |
First Author: |
Poulin EJ |
Year: |
2019 |
Journal: |
Cancer Discov |
Title: |
Tissue-Specific Oncogenic Activity of KRASA146T. |
Volume: |
9 |
Issue: |
6 |
Pages: |
738-755 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang L |
Year: |
2019 |
Journal: |
Genes Dev |
Title: |
ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis. |
Volume: |
33 |
Issue: |
11-12 |
Pages: |
641-655 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tomić G |
Year: |
2024 |
Journal: |
Cell Rep |
Title: |
Palmitoyl transferase ZDHHC20 promotes pancreatic cancer metastasis. |
Volume: |
43 |
Issue: |
5 |
Pages: |
114224 |
|
•
•
•
•
•
|
Publication |
First Author: |
Perkail S |
Year: |
2020 |
Journal: |
Nat Commun |
Title: |
BAP1 is a haploinsufficient tumor suppressor linking chronic pancreatitis to pancreatic cancer in mice. |
Volume: |
11 |
Issue: |
1 |
Pages: |
3018 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lin WC |
Year: |
2013 |
Journal: |
Cancer Res |
Title: |
Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer. |
Volume: |
73 |
Issue: |
6 |
Pages: |
1821-30 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kopinke D |
Year: |
2011 |
Journal: |
Development |
Title: |
Lineage tracing reveals the dynamic contribution of Hes1+ cells to the developing and adult pancreas. |
Volume: |
138 |
Issue: |
3 |
Pages: |
431-41 |
|
•
•
•
•
•
|
Publication |
First Author: |
Morris JP 4th |
Year: |
2010 |
Journal: |
J Clin Invest |
Title: |
Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice. |
Volume: |
120 |
Issue: |
2 |
Pages: |
508-20 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim I |
Year: |
2009 |
Journal: |
J Am Soc Nephrol |
Title: |
Conditional mutation of Pkd2 causes cystogenesis and upregulates beta-catenin. |
Volume: |
20 |
Issue: |
12 |
Pages: |
2556-69 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bednar F |
Year: |
2015 |
Journal: |
Carcinogenesis |
Title: |
Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism. |
Volume: |
36 |
Issue: |
7 |
Pages: |
730-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sodir NM |
Year: |
2022 |
Journal: |
Nat Commun |
Title: |
Reversible Myc hypomorphism identifies a key Myc-dependency in early cancer evolution. |
Volume: |
13 |
Issue: |
1 |
Pages: |
6782 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shi Y |
Year: |
2019 |
Journal: |
Nature |
Title: |
Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. |
Volume: |
569 |
Issue: |
7754 |
Pages: |
131-135 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rath N |
Year: |
2017 |
Journal: |
EMBO Mol Med |
Title: |
ROCK signaling promotes collagen remodeling to facilitate invasive pancreatic ductal adenocarcinoma tumor cell growth. |
Volume: |
9 |
Issue: |
2 |
Pages: |
198-218 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cheung PF |
Year: |
2018 |
Journal: |
Cancer Res |
Title: |
Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting. |
Volume: |
78 |
Issue: |
17 |
Pages: |
4997-5010 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fox RG |
Year: |
2016 |
Journal: |
Nature |
Title: |
Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma. |
Volume: |
534 |
Issue: |
7607 |
Pages: |
407-411 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mahadevan KK |
Year: |
2023 |
Journal: |
Dev Cell |
Title: |
Elimination of oncogenic KRAS in genetic mouse models eradicates pancreatic cancer by inducing FAS-dependent apoptosis by CD8(+) T cells. |
Volume: |
58 |
Issue: |
17 |
Pages: |
1562-1577.e8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Talbert EE |
Year: |
2019 |
Journal: |
Cell Rep |
Title: |
Modeling Human Cancer-induced Cachexia. |
Volume: |
28 |
Issue: |
6 |
Pages: |
1612-1622.e4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhu Y |
Year: |
2017 |
Journal: |
Immunity |
Title: |
Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression. |
Volume: |
47 |
Issue: |
2 |
Pages: |
323-338.e6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dow LE |
Year: |
2014 |
Journal: |
PLoS One |
Title: |
Conditional reverse tet-transactivator mouse strains for the efficient induction of TRE-regulated transgenes in mice. |
Volume: |
9 |
Issue: |
4 |
Pages: |
e95236 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhou Y |
Year: |
2014 |
Journal: |
J Biol Chem |
Title: |
Proteome analysis and conditional deletion of the EAAT2 glutamate transporter provide evidence against a role of EAAT2 in pancreatic insulin secretion in mice. |
Volume: |
289 |
Issue: |
3 |
Pages: |
1329-44 |
|
•
•
•
•
•
|
Publication |
First Author: |
Vincent DF |
Year: |
2010 |
Journal: |
Genesis |
Title: |
A rapid strategy to detect the recombined allele in LSL-TβRICA transgenic mice. |
Volume: |
48 |
Issue: |
9 |
Pages: |
559-62 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shrestha H |
Year: |
2024 |
Journal: |
Cell Rep |
Title: |
The Janus kinase 1 is critical for pancreatic cancer initiation and progression. |
Volume: |
43 |
Issue: |
5 |
Pages: |
114202 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bufe B |
Year: |
2019 |
Journal: |
Nat Commun |
Title: |
Bacterial MgrB peptide activates chemoreceptor Fpr3 in mouse accessory olfactory system and drives avoidance behaviour. |
Volume: |
10 |
Issue: |
1 |
Pages: |
4889 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kalisz M |
Year: |
2020 |
Journal: |
EMBO J |
Title: |
HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer. |
Volume: |
39 |
Issue: |
9 |
Pages: |
e102808 |
|
•
•
•
•
•
|
Publication |
First Author: |
Smukler SR |
Year: |
2011 |
Journal: |
Cell Stem Cell |
Title: |
The adult mouse and human pancreas contain rare multipotent stem cells that express insulin. |
Volume: |
8 |
Issue: |
3 |
Pages: |
281-93 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xue J |
Year: |
2019 |
Journal: |
Cell Rep |
Title: |
CDK8 Regulates Insulin Secretion and Mediates Postnatal and Stress-Induced Expression of Neuropeptides in Pancreatic β Cells. |
Volume: |
28 |
Issue: |
11 |
Pages: |
2892-2904.e7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liu G |
Year: |
2015 |
Journal: |
Hum Mol Genet |
Title: |
Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression. |
Volume: |
24 |
Issue: |
18 |
Pages: |
5299-312 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tsuda M |
Year: |
2018 |
Journal: |
J Clin Invest |
Title: |
The BRG1/SOX9 axis is critical for acinar cell-derived pancreatic tumorigenesis. |
Volume: |
128 |
Issue: |
8 |
Pages: |
3475-3489 |
|
•
•
•
•
•
|
Publication |
First Author: |
Huang H |
Year: |
2022 |
Journal: |
Cancer Cell |
Title: |
Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer. |
Volume: |
40 |
Issue: |
6 |
Pages: |
656-673.e7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mizutani Y |
Year: |
2019 |
Journal: |
Cancer Res |
Title: |
Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis. |
Volume: |
79 |
Issue: |
20 |
Pages: |
5367-5381 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen Y |
Year: |
2018 |
Journal: |
EMBO Mol Med |
Title: |
Dual reporter genetic mouse models of pancreatic cancer identify an epithelial-to-mesenchymal transition-independent metastasis program. |
Volume: |
10 |
Issue: |
10 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Crittenden MR |
Year: |
2018 |
Journal: |
Sci Rep |
Title: |
Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity. |
Volume: |
8 |
Issue: |
1 |
Pages: |
7012 |
|
•
•
•
•
•
|
Publication |
First Author: |
Falcomatà C |
Year: |
2022 |
Journal: |
Nat Cancer |
Title: |
Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment. |
Volume: |
3 |
Issue: |
3 |
Pages: |
318-336 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rovira M |
Year: |
2021 |
Journal: |
Genes Dev |
Title: |
REST is a major negative regulator of endocrine differentiation during pancreas organogenesis. |
Volume: |
35 |
Issue: |
17-18 |
Pages: |
1229-1242 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lacombe J |
Year: |
2023 |
Journal: |
Cell Rep |
Title: |
Vitamin K-dependent carboxylation regulates Ca(2+) flux and adaptation to metabolic stress in β cells. |
Volume: |
42 |
Issue: |
5 |
Pages: |
112500 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mameishvili E |
Year: |
2019 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Aldh1b1 expression defines progenitor cells in the adult pancreas and is required for Kras-induced pancreatic cancer. |
Volume: |
116 |
Issue: |
41 |
Pages: |
20679-20688 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dickerson MT |
Year: |
2022 |
Journal: |
Nat Commun |
Title: |
G(i/o) protein-coupled receptor inhibition of beta-cell electrical excitability and insulin secretion depends on Na(+)/K(+) ATPase activation. |
Volume: |
13 |
Issue: |
1 |
Pages: |
6461 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
642
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
501
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Chung KM |
Year: |
2020 |
Journal: |
Cell |
Title: |
Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal Adenocarcinoma. |
Volume: |
181 |
Issue: |
4 |
Pages: |
832-847.e18 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ramakrishnan G |
Year: |
2022 |
Journal: |
Cell Rep |
Title: |
NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma. |
Volume: |
41 |
Issue: |
6 |
Pages: |
111623 |
|
•
•
•
•
•
|
Publication |
First Author: |
Muzumdar MD |
Year: |
2016 |
Journal: |
Nat Commun |
Title: |
Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers. |
Volume: |
7 |
|
Pages: |
12685 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nakamura T |
Year: |
2023 |
Journal: |
J Pathol |
Title: |
ELF3 suppresses gallbladder cancer development through downregulation of the EREG/EGFR/mTOR complex 1 signalling pathway. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Byrne KT |
Year: |
2016 |
Journal: |
Cell Rep |
Title: |
CD40 Stimulation Obviates Innate Sensors and Drives T Cell Immunity in Cancer. |
Volume: |
15 |
Issue: |
12 |
Pages: |
2719-32 |
|
•
•
•
•
•
|
Publication |
First Author: |
Barilla RM |
Year: |
2019 |
Journal: |
Nat Commun |
Title: |
Specialized dendritic cells induce tumor-promoting IL-10+IL-17+ FoxP3neg regulatory CD4+ T cells in pancreatic carcinoma. |
Volume: |
10 |
Issue: |
1 |
Pages: |
1424 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yu R |
Year: |
2016 |
Journal: |
Mol Cell Endocrinol |
Title: |
Animal models of spontaneous pancreatic neuroendocrine tumors. |
Volume: |
421 |
|
Pages: |
60-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shakya R |
Year: |
2011 |
Journal: |
Science |
Title: |
BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity. |
Volume: |
334 |
Issue: |
6055 |
Pages: |
525-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rajbhandari N |
Year: |
2017 |
Journal: |
Cell Rep |
Title: |
Autocrine IGF1 Signaling Mediates Pancreatic Tumor Cell Dormancy in the Absence of Oncogenic Drivers. |
Volume: |
18 |
Issue: |
9 |
Pages: |
2243-2255 |
|
•
•
•
•
•
|
Publication |
First Author: |
Morton JP |
Year: |
2010 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. |
Volume: |
107 |
Issue: |
1 |
Pages: |
246-51 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tomita H |
Year: |
2021 |
Journal: |
Cell Rep |
Title: |
Inhibition of FGF10-ERK signal activation suppresses intraductal papillary neoplasm of the bile duct and its associated carcinomas. |
Volume: |
34 |
Issue: |
8 |
Pages: |
108772 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shrivastava V |
Year: |
2021 |
Journal: |
Sci Rep |
Title: |
Beta cell adaptation to pregnancy requires prolactin action on both beta and non-beta cells. |
Volume: |
11 |
Issue: |
1 |
Pages: |
10372 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gruber R |
Year: |
2016 |
Journal: |
Gastroenterology |
Title: |
YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling. |
Volume: |
151 |
Issue: |
3 |
Pages: |
526-39 |
|
•
•
•
•
•
|
Publication |
First Author: |
Genovese G |
Year: |
2017 |
Journal: |
Nature |
Title: |
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. |
Volume: |
542 |
Issue: |
7641 |
Pages: |
362-366 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chambers AP |
Year: |
2017 |
Journal: |
Cell Metab |
Title: |
The Role of Pancreatic Preproglucagon in Glucose Homeostasis in Mice. |
Volume: |
25 |
Issue: |
4 |
Pages: |
927-934.e3 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sakamoto K |
Year: |
2020 |
Journal: |
Sci Rep |
Title: |
Efficient tissue-type specific expression of target genes in a tetracycline-controlled manner from the ubiquitously active Eef1a1 locus. |
Volume: |
10 |
Issue: |
1 |
Pages: |
207 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chang H |
Year: |
2019 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Efficient genome-wide first-generation phenotypic screening system in mice using the piggyBac transposon. |
Volume: |
116 |
Issue: |
37 |
Pages: |
18507-18516 |
|
•
•
•
•
•
|
Publication |
First Author: |
Song J |
Year: |
2010 |
Journal: |
Genesis |
Title: |
Brain expression of Cre recombinase driven by pancreas-specific promoters. |
Volume: |
48 |
Issue: |
11 |
Pages: |
628-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim H |
Year: |
2018 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Ectopic serotonin production in β-cell specific transgenic mice. |
Volume: |
495 |
Issue: |
2 |
Pages: |
1986-1991 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rad R |
Year: |
2015 |
Journal: |
Nat Genet |
Title: |
A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic cancer. |
Volume: |
47 |
Issue: |
1 |
Pages: |
47-56 |
|
•
•
•
•
•
|